The nucleocytoplasmic transport system is essential for maintaining cell viability; transport of proteins and nucleic acids between the nucleus and the cytoplasm occurs through nuclear pore complexes (NPCs). In this study, we examined the immunohistochemical distribution of the major protein components of NPCs, Nup62, Nup88, and Nup153, in spinal cords from controls and patients with sporadic or familial amyotrophic lateral sclerosis (SALS or FALS) and its mouse model. In control subjects, immunolabeling on the nuclear envelopes of anterior horn cells (AHCs) was invariably smooth and continuous, whereas in SALS and FALS patients, the AHCs predominantly showed irregular nuclear contours. Double immunofluorescence staining demonstrated that in SALS patients, importin-A immunoreactivity was absent in the nuclei in a subset of AHCs; in these cells, Nup62 immunolabeling of nuclear membrane was invariably irregular, suggesting that there was dysfunctional nucleocytoplasmic transport in those AHCs. In the mouse model, Nup62-immunolabeled AHCs with irregular nuclear contours were predominant as early as the presymptomatic stage and the contours became progressively discontinuous along with disease development. Together, these observations suggest that dysfunctional nucleocytoplasmic transport may underlie the pathogenesis of ALS.
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by a relentless destruction of motor neurons; it manifests clinically as progressive weakness leading to death within a few years. Approximately 10% of ALS cases are familial. In approximately 15% of these patients, the disease is caused by dominantly inherited mutations in the copper-and zinc-dependent superoxide dismutase (SOD1) gene (1) . Although several hypotheses have been proposed concerning the pathogenesis of sporadic ALS (SALS) and of familial ALS (FALS), the specific mechanisms remain unclear and effective treatment is not currently available.
We recently reported altered immunohistochemical localization of proteins associated with the nucleocytoplasmic transport system (i.e. importin-A and importin->) in the lumbar spinal cord of ALS model mice (2) . The immunoreactivities of these proteins in the surviving anterior horn cells (AHCs) showed a significant progressive decrease in the nucleus and an increase in the cytoplasm as the disease progressed. In view of these results, we hypothesized that dysfunctional nucleocytoplasmic transport might be involved in the pathogenesis of ALS. Moreover, we demonstrated that certain representative cargo proteins transported into the nucleus in an importin-A/>Ydependent, importin-A familydependent only, or importin-A/>Yindependent manner showed a similar abnormal distribution as importin-A/>. These findings prompted us to hypothesize that dysfunction of the nuclear pore complexes (NPCs) may underlie this abnormal localization.
The NPC in vertebrates is a 60-to 125-MDa structure spanning the plane of the nuclear envelope and is composed of approximately 30 distinct structural proteins known as nucleoporins (3Y6). Among them, Nup358 and Nup88, Nup62, and Nup153, which are in the cytoplasmic, central, and nucleoplasmic regions of the NPC, respectively, have been proposed to provide sequential binding sites for the passage of importin-A into the nucleus ( Fig. 1) (7, 8) . The importin-A transport complex binds to nucleoporins with progressively increasing affinity as the complex moves from Nup358 to the Nup62 complex and then to Nup153. Therefore, it is assumed that these nucleoporins play an important role in the interactions between the cytoplasmic and nuclear transport processes.
The NPCs have been investigated in certain disorders, for example, primary biliary cirrhosis, neoplasms, and viral infections (9) . Little is known, however, about NPCs in neurodegenerative disorders. Sheffield et al (10) recently
MATERIALS AND METHODS
Lumbar spinal cord tissue was obtained from clinically and neuropathologically proven SALS (7 cases) and FALS (4 cases) patients; the latter had a confirmed heterozygous 1-amino acid substitution in the gene encoding SOD1 (3 patients with an alanine to valine substitution at codon 4 (A4V) (11) and 1 case with an isoleucine to threonine substitution at codon 113 (I113T). The spinal cords from 6 age-matched neurologically and neuropathologically normal individuals served as controls. The clinical profiles of these cases are summarized in Table 1 . The spinal cords were fixed for several weeks in 10% neutral formalin, sliced, embedded in paraffin, and cut into 7-Km-thick sections.
For mouse tissue samples, founder male mice heterozygous for the ALS-linked G93A mutation of the human gene for SOD1 (TgN[B6SJL-Tg{SOD1-G93A}1Gur]) (12) and female nontransgenic B6SJLF1/J mice originally obtained from the Jackson Laboratory (Bar Harbor, ME) were crossed in the Kansai Medical University animal facility. All animal breeding and the experimental protocols were approved by the Institutional Committee for Animal Safety and Welfare of Kansai Medical University and are in agreement with the Guidelines from the National Institutes of Health on the use of live animals. Animals were genotyped using an ASTEC research thermal cycler for polymerase chain reaction amplification of mouse DNA extracted from tail snips as previously described (1, 13) .
G93A SOD1 transgenic (Tg) female mice (n = 5) were used in each of 4 age groups as follows: 8 to 11 weeks (presymptomatic stage of the progression of the motor dysfunction); 12 to 14 weeks (early symptomatic); 15 to FIGURE 1. Schematic representation of the structure of a nuclear pore complex. The locations of Nup358 and Nup88, components of the cytoplasmic filament, Nup62, a component of the central core, and Nup153, a component of the nuclear basket, are depicted. ImpA, importin-A; Nup, nuclear pore complex proteins. The human and murine sections were deparaffinized and stained with hematoxylin and eosin (H&E). After having been photographed, the sections were decolorized and then immunostained with a mouse monoclonal antibody (mAb) against Nup62 (BD Transduction, San Diego, CA) diluted 1:1000 for mouse sections, 1:500 for human sections), mouse anti-Nup88 mAb (BD Transduction) was used at 1:1000 after pretreatment with 98.0% formic acid (Wako, Osaka, Japan) for 5 minutes at room temperature; mouse anti-Nup153 mAb (1:250; Abcam Inc, Cambridge, MA) was used after pretreatment with heat retrieval for 5 minutes in 10 mmol/L citrate buffer in a microwave oven. Incubation was carried out overnight at 4-C. Bound primary antibody was detected with the appropriate Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA); 3,3 ¶-diaminobenzidine tetrahydrochloride was used as the chromogen. Sections from the Tg mice also stained with anti<active caspase-3 antibody (rabbit polyclonal, 1:40,000, BD PharMingen, San Diego, CA) after pretreatment with heat retrieval were photographed and then restained with the anti-Nup62 antibody.
Double immunofluorescence staining on lumbar sections from control and SALS cases was performed using the antiYimportin-A antibody (mouse mAb, 1:50; BD Bioscience) and anti-Nup62 antibody (1:100). These primary antibodies were detected with Alexa Fluor 546 goat anti<rabbit IgG (1:200; Molecular Probes, Eugene, OR) and Alexa Fluor 488 goat anti-mouse IgG (1:200; Molecular Probes). The slides were mounted with Vectashield (Vector) and observed with a Zeiss LSM 510 META confocal microscope.
Staining specificity was assessed by substituting the primary antibodies with the appropriate amount of nonimmune serum or PBS solution containing 3% bovine serum albumin or by preincubating the primary antibodies with an excess of the peptide immunogen. No reaction product was seen in these control sections (not shown).
Under 400Â magnification, we investigated nonadjacent sections immunostained with the anti-Nup62 antibody that provided optimal labeling with low background and classified the AHCs with clearly visible nucleoli into those having smooth or irregular nuclear contours. When there was a ruffled edge or redundant or tortuous contour, the nucleus was classified as irregular. The nuclear contours of AHCs that had nuclei larger than 15 and 10 Km in diameter in human and murine materials, respectively, were evaluated. We further distinguished these AHCs with irregular nuclear contours into those with nuclear rims with continuous (i.e. entire) and with discontinuous staining.
The mean and SDs of the cell count for each of these 3 categories in 3 sections from each of the patients with SALS or FALS and the control cases and in 5 sections from each of the mouse groups were determined; we then calculated the percentage of cells in each category. Statistical analysis of the mean percentage of each category in the Tg and Wt mice was carried out using Student t-test.
RESULTS
The antibodies against Nup62, Nup88, and Nup153 gave similar immunohistochemical results in sections from control subjects, SALS and FALS cases, and the Tg and Wt mice. In control individuals, immunoreactivities for these nucleoporins were observed as entirely smooth nuclear contours in all AHCs investigated (Figs. 2A, D) , whereas the AHCs of both the SALS and the FALS patients predominantly had redundant or tortuous nuclear contours with ruffled edges; these were defined as having an irregular nuclear contour (Figs. 2B, C, E, F) . Notably, the nucleoporinimmunolabeled nuclear irregularity was observed even on normal-looking H&E-stained AHC nuclei after destaining and restaining with anti-Nup62 (Figs. 2G, H) . Double immunofluorescence revealed that the AHC of the controls showed immunoreactivity for importin-A within both the cytoplasm and the nucleus, although the staining intensity of each varied; their nuclear envelopes labeled for Nup62 showed smooth contours (Figs. 3AYC) . By contrast, the AHCs in SALS patients that showed irregular nuclear contours with the anti-Nup62 antibody invariably lacked immunoreactivity for importin-A within their nuclei (Figs. 3DYF) . The small numbers of the remaining AHCs with smooth nuclear contours in these patients showed immunostaining patterns for importin-A similar to those of the controls. These findings are consistent with our previous observations that in ALS model mice, importin-A immunoreactivity is decreased within the nuclei and increased within the cytoplasm of a subset of the surviving AHCs (2) .
Semiquantitative analysis of the lumbar AHCs stained with anti-Nup62 antibody revealed that all of the AHCs observed in the control subjects had smooth nuclear contours (Table 2) . By contrast, in 6 patients of the 7 SALS (Cases 2Y7), more than 87.5% of the AHCs had irregular nuclear rims. In Case 1, the lumbar AHCs with smooth contours were more frequent (53.0%) than those in the other SALS cases. This patient presented with bulbar palsy at the onset of disease and died because of respiratory failure after a short clinical course (12 months). She was ambulatory until death, suggesting that the lumbar spinal cord might be less affected at autopsy. On the other hand, in Case 7, whose total duration was 72 months (including 48 months under artificial ventilation), several AHCs showed irregular/discontinuous nuclear contours in addition to the irregular/continuous nuclear contours. Irrespective of the type of mutation, most of the AHCs in the FALS cases had irregular/continuous nuclear contours similar to those in most of the SALS cases ( Table 2 ). In all of the ALS patients, skeinlike or round hyaline inclusions in SALS and Lewy body-like hyaline inclusions (Cases 8Y10) or conglomerate inclusions (Case 11) in FALS were recognized in the cytoplasm and the neurites of AHCs. The nuclear contours of the AHC with a visible nucleolus and possessing these inclusions were invariably irregular with anti-Nup62 antibody (100% T 0%), although the number of such AHCs was sparse per section in all of the patients. On the other hand, the percentages (mean T SD) of AHCs devoid of visible inclusions but having an irregular nuclear contour in SALS and FALS were 88.3% T 20.8% and 95.3% T 9.5%, respectively. The prevalence of nuclear irregularities in AHCs with and without inclusions in SALS and FALS were not significantly different (p = 0.09 and p = 0.20, respectively).
In the Wt mouse AHCs, the immunoreactivities for the nucleoporins were distributed predominantly as smooth nuclear contours (Fig. 4A) . The antibodies used for these sections yielded similar immunohistochemical results irrespective of age, indicating that no age-related changes occurred in the immunohistochemical distributions at least in mice aged between 8 and 20 weeks. On the other hand, in the AHCs of Tg mice, there were irregular/continuous (Fig. 4B ) and irregular/discontinuous (Fig. 4C ) nuclear contours. To investigate a possible correlation between the nuclear contour irregularity and apoptotic processes, we applied a restaining technique using anti<active caspase-3 and antiNup62 antibodies to sections from the Tg mice. Active caspase-3 immunoreactivity was observed in the cytoplasm of a subset of the surviving AHCs (Fig. 4D) . On restaining, we encountered instances of AHCs with an irregular nuclear rim stained with anti-Nup62 antibody in the same neurons lacking anti-active caspase-3 immunoreactivity (Figs. 4E, F ) . This finding suggests that the nucleoporin-immunolabeled nuclear irregularity would unlikely be a consequence of apoptosis.
The results of chronological quantitative analysis of the ALS model mice are shown in Figure 5 . In the control mice, Nup62 immunoreactivity was observed along the nuclear rims as smooth contours in most of the AHCs. In contrast, the AHCs with smooth nuclear contours from the Tg mice were significantly few as early as in the presymptomatic stage compared with those of the control mice and were not observed at all in the middle and the late symptomatic Tg mice. The percentages of AHCs with smooth nuclear contours were significantly lower in the symptomatic Tg mice, whereas the proportions of AHCs with an irregular and continuous nuclear contour were higher at the presymptomatic stage of Tg mice than that of the Wt mice; they increased to reach a strongly significant difference at the early symptomatic stage and then decreased. The AHCs with an irregular and discontinuous nuclear contour were first recognizable at the presymptomatic stage (the percentage of this type increased to be significantly high at symptom onset) and became the most common type of AHC at the late symptomatic stage. These results imply that the Nup62-immunolabeled nuclear contours become disrupted along with disease progression and parallel our observations in SALS patients.
DISCUSSION
This is the first demonstration of nuclear contour irregularities in the surviving AHCs of SALS and FALS patients and in AHCs of ALS model mice. These abnormalities are associated with an apparent impairment in importation of importin-A into the AHC nuclei. Our results imply that these dysfunctional NPCs could be involved in the pathogenesis underlying ALS.
The nucleoporin-immunolabeled nuclear irregularity identified in our study is very similar to that observed by Sheffield et al (10) in the hippocampal neurons from AD cases. Moreover, these investigators demonstrated abnormal accumulation of nuclear transport factor 2, a protein carrying RanGDP from the cytoplasm into the nucleus, in the cytoplasm of hippocampal pyramidal cells and postulated that faulty NPCs and nucleocytoplasmic transport are involved in the pathogenesis of AD. Nuclear transport factor 2 is known to be actively transported into the nucleus through the NPCs by binding to Nup62 (14) , as in the case of importin-A. Taken together, these studies suggest that the nuclear irregularities represent a functional disturbance of NPCs, and that there may be common pathogenetic processes of neurodegeneration in AD and ALS.
We also demonstrated that progressive disruption of the nuclear contours delineated by Nup62 immunohistochemistry correlated with disease progression in ALS model mice. The mechanism responsible for the discontinuous nucleoporin immunolabeling on the nuclear envelope remains to be elucidated, but it might represent a loss of antigenicity because of nucleoporin degeneration or a severely uneven distribution of NPCs on the nuclear membrane. Nevertheless, our findings that the AHCs with irregular nuclear contours in the ALS model mice were increased over controls even at the presymptomatic stages as well as progressing over time suggest that the nucleoporin-immunolabeled nuclear irregularity is related to the pathogenesis.
The NPCs are known to undergo strong modifications, such as disassembly during apoptosis (15, 16) , but no clear relationship was identified between the changes in nucleoporin distribution and apoptosis in AD (10) . In the present study, we identified instances with nuclear contour irregularity in the absence of immunoreactivity for caspase-3. Activated caspase-3 is one of the effector caspases commonly situated most downstream of several distinct apoptotic cascades. Therefore, AHCs immunopositive for active caspase-3 are assumed to be at the final stage of the caspase cascade in cells undergoing apoptosis. Indeed, nuclear modification might develop at earlier stages of apoptotic cascades. If the nuclear irregularity is a consequence of apoptosis, however, it would be unlikely that the irregular nuclear rim reverses to the smooth contour during the apoptotic process progressing to the stage of caspase-3 activation. We thus consider that, as in AD, the AHC nuclear contour irregularities in ALS may not be related to apoptosis.
Among several hypotheses proposed on the pathogenesis of ALS, we recently postulated that dysfunctional nucleocytoplasmic transport might impair successful transport of beneficial regeneration signals into the nucleus (2) . A dysfunctional nucleocytoplasmic transport system has been proposed to operate in triple A syndrome. This rare disorder is caused by mutations in a gene that encodes the nucleoporin ALADIN (17) . ALADIN-defective NPCs have an impaired importin-A/>Ymediated import pathway and show weak nuclear import of aprataxin, a repair protein for DNA single-stand breaks, and DNA ligase I, which results in increased susceptibility of cells to oxidative stress and leads to the accumulation of damaged DNA and cell death (17) . Similarly in ALS and AD, therefore, beneficial regeneration signals may not be transported into the nucleus, thereby resulting in facilitation of neurodegeneration.
We recently demonstrated that the nuclear staining intensity of phosphorylated Smad2/3 was reduced in AHCs with round hyaline inclusions in brain specimens from SALS patients (18) . Phosphorylated Smad2/3 is supposed to enter the nucleus by direct interaction with Nup214 and Nup153, components of the NPCs. Therefore, in view of our present findings, the nuclear contour irregularity as a consequence of possible dysfunctional NPCs in ALS might be involved in impairment of phosphorylated Smad2/3 translocation from the cytoplasm to the nucleus. Beneficial transforming growth factor-A signal transduction would therefore be impaired at the step of Smad2/3 translocation into the nucleus in SALS patients.
Recently, transactivation response DNA-binding protein 43 (TDP-43) has been proposed to be involved in the pathogenesis of ALS. Winton et al (19) demonstrated cytoplasmic aggregate formation in cultured cells expressing mutant TDP-43 with defective nuclear localizing signals and speculated that deleterious perturbation of nuclear trafficking and solubility of TDP-43 may be linked to ALS pathogenesis.
More recently, NPCs were reported to deteriorate in an age-related manner, leading to an increase in nuclear permeability and leakage of proteins (20) . In that study, the authors demonstrated that a subset of nucleoporins is oxidatively damaged in old cells, suggesting that the accumulation of damage at the NPC might be related to neurodegeneration (20, 21) . Further investigations are needed to elucidate the significance of the nuclear contour irregularities and the signal transduction systems involved in the pathogenesis of ALS.
